Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 28, 2008Hepatology

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial

View Full Paper
Ask AI
Bookmark
Share

Authors

MYMing‐Lung YuNational Sun Yat-sen UniversityCDChia‐Yen DaiKaohsiung Medical UniversityJHJee‐Fu HuangKaohsiung Medical University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yu et al. (2008) studied this question.

synapsesocial.com/papers/6a95b005a3302b5b459209d3https://doi.org/10.1002/hep.22319
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of Asian Race on Response to Combination Therapy With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C2007 · 90 citations
  2. 2Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial2007 · 250 citations
  3. 3Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 32005 · 841 citations
  4. 4A randomized trial of 24‐ vs. 48‐week courses of PEG interferon α‐2b plus ribavirin for genotype‐1b‐infected chronic hepatitis C patients: a pilot study in Taiwan2005 · 44 citations
  5. 5A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C2006 · 287 citations